Strides Pharma Science (Strides) has received the United States Food & Drug Administration (USFDA) approval for its greenfield oral dosage facility in Singapore. With the commercialization of its manufacturing facility in Singapore, Strides will join the league of global pharmaceutical companies having a Manufacturing and Research and Development footprint in Singapore.
The facility will complement Strides’ existing manufacturing base and will help meet increased demand from its fast?growing regulated markets business across US, Australia, UK and Europe. The facility operating at its peak capacity will produce around 1.4 billion tablets and hard gelatin capsules.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
